Stay updated on ARO-APOC3 in FCS Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in FCS Clinical Trial page.
Latest updates to the ARO-APOC3 in FCS Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page; no study content or core details were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check11 days agoChange DetectedPublications section now includes a note that items are auto-filled from PubMed and may not all be about the study, and the page revision label was updated to v3.3.1. This is a metadata/update and does not change study details or eligibility criteria.SummaryDifference0.1%
- Check18 days agoChange DetectedRemoved the government funding lapse notice from the page, removing a site-wide operating-status message. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check32 days agoChange DetectedNo significant changes to the study details, eligibility criteria, outcomes, or recruitment status are evident between the screenshots. Any observed differences appear to be formatting or styling adjustments only.SummaryDifference0.3%
- Check61 days agoChange DetectedVersion update from v3.1.0 to v3.2.0 with new funding/status notices and a new genetic disorder topic.SummaryDifference4%
- Check68 days agoChange Detected- Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and - added a new Revision: v3.1.0.SummaryDifference0.6%
Stay in the know with updates to ARO-APOC3 in FCS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in FCS Clinical Trial page.